Clinical Trials

52 enrolled

Nasopharyngeal Carcinoma

NCT05389306 2026-03-03

NPC-LN

348 enrolled

Nasopharyngeal Carcinoma, Disease

NCT01365169 2026-01-07

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

GastrointestinalHead & Neck

590 enrolled

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Somatostatinoma, Colorectal Neoplasms

NCT07248696 2025-11-25

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

Phase NA Active not recruiting

32 enrolled

Nasopharyngeal Carcinoma

NCT07019870 2025-06-13

Screening for Early Diagnosis of Nose Cancer

20,000 enrolled

Nasopharyngeal Carcinoma

NCT04823468 2025-06-10

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

236 enrolled

Nasopharyngeal Carcinoma, Body Weight

NCT05741008 2025-04-27

Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma

20 enrolled

Nasopharyngeal Carcinoma

NCT06870435 2025-03-11

Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas

68,649 enrolled

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT06389201 2025-02-18

Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients

30 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT06796270 2025-01-28

Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma

24 enrolled

Nasopharyngeal Carcinoma

NCT05834712 2025-01-27

Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention

224 enrolled

Nasopharyngeal Carcinoma

NCT05292027 2024-12-31

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

84 enrolled

Nasopharyngeal Carcinoma

NCT06017895 2024-12-27

Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma

178 enrolled

Nasopharyngeal Carcinoma, Stomatitis

NCT06688760 2024-11-14

Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma

86 enrolled

Nasopharyngeal Carcinoma

NCT06676293 2024-11-07

Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma

8 enrolled

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma

NCT06572293 2024-10-16

Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma

250 enrolled

Nasopharyngeal Carcinoma

NCT04417985 2024-08-21

Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma

112 enrolled

Nasopharyngeal Carcinoma

NCT05892354 2024-08-07

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

190 enrolled

Nasopharyngeal Carcinoma, Stomatitis

NCT06533267 2024-08-01

Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.

442 enrolled

Nasopharyngeal Carcinoma

NCT06529562 2024-07-31

Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.

384 enrolled

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma

NCT06472024 2024-06-26

Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study

30 enrolled

Head & NeckOther

Nasopharyngeal Carcinoma, Neoplasms, Mucositis

NCT06442709 2024-06-04

Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients

100 enrolled

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT04995185 2024-05-16

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

9 enrolled

Nasopharyngeal Carcinoma, Hypoxia, Nasopharyngeal Neoplasms

NCT06268600 2024-04-11

The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma

320 enrolled

Nasopharyngeal Carcinoma, Hypothyroidism, Nasopharyngeal Neoplasms

NCT06313450 2024-03-19

De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma

112 enrolled

Nasopharyngeal Carcinoma

NCT06189482 2024-03-12

NPC

Phase NA Terminated

56 enrolled

Nasopharyngeal Carcinoma, Deglutition Disorders

NCT06248840 2024-03-07

Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma

Phase NA Terminated

56 enrolled

Nasopharyngeal Carcinoma

NCT03788499 2024-02-23

Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis

160 enrolled

Nasopharyngeal Carcinoma

NCT04593186 2023-09-07

Magnifying NBI for Occult NPC

246 enrolled

Nasopharyngeal Carcinoma

NCT05994170 2023-08-16

CTVp1-NPC

454 enrolled

Nasopharyngeal Carcinoma

NCT03598218 2023-08-03

Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma

30 enrolled

Nasopharyngeal Carcinoma

NCT05771025 2023-05-19

Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver Metastases

55 enrolled

Nasopharyngeal Carcinoma

NCT03429868 2023-05-10

PET and MRI in Prognosis Prediction of NPC

180 enrolled

Nasopharyngeal Carcinoma

NCT05717790 2023-02-08

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

288 enrolled

Phase NA Not yet recruiting

Nasopharyngeal Carcinoma

NCT05622474 2022-11-18

A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy

236 enrolled

Nasopharyngeal Carcinoma

NCT05449184 2022-07-08

A Prospective, Randomized, Controlled Clinical Study of BET Combined With Tympanostomy Tube Insertion in the Treatment of Intractable OME After Radiotherapy for NPC

208 enrolled

Nasopharyngeal Carcinoma, Otitis Media with Effusion

NCT05352321 2022-07-01

Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma

264 enrolled

Nasopharyngeal Carcinoma

NCT05432219 2022-06-27

A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma

20 enrolled

Nasopharyngeal Carcinoma

NCT03346109 2022-04-06

To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma

568 enrolled

Nasopharyngeal Carcinoma

NCT05228093 2022-02-08

A Randomized Controlled Clinical Trial of Surgery Versus Conservative Treatment for Mild and Moderate-grade Nasopharyngeal Necrosis

216 enrolled

Nasopharyngeal Carcinoma, Necrosis

NCT02289807 2021-10-15

Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy

Phase NA Withdrawn

Nasopharyngeal Carcinoma

NCT03942380 2021-09-21

Cell-free Tumor DNA in Head and Neck Cancer Patients

500 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms

NCT05008471 2021-08-17

Application of Whole-course Standardized Nutrition Management During Peri-radiotherapy in Patients With Nasopharyngeal Carcinoma After Radiotherapy: a Multicenter Randomized Controlled Clinical Study

388 enrolled

Nasopharyngeal Carcinoma, Nutrition Disorders

NCT03353467 2021-06-03

Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients

228 enrolled